BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17234537)

  • 1. Efficacy of lycopene in the management of oral submucous fibrosis.
    Kumar A; Bagewadi A; Keluskar V; Singh M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):207-13. PubMed ID: 17234537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan.
    Goel S; Ahmed J
    J Cancer Res Ther; 2015; 11(1):113-8. PubMed ID: 25879347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of newer antioxidant lycopene in the treatment of oral submucous fibrosis.
    Karemore TV; Motwani M
    Indian J Dent Res; 2012; 23(4):524-8. PubMed ID: 23257490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis.
    Shetty P; Shenai P; Chatra L; Rao PK
    Indian J Dent Res; 2013; 24(3):347-50. PubMed ID: 24025883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral lycopene in the treatment of oral leukoplakia.
    Singh M; Krishanappa R; Bagewadi A; Keluskar V
    Oral Oncol; 2004 Jul; 40(6):591-6. PubMed ID: 15063387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.
    Saran G; Umapathy D; Misra N; Channaiah SG; Singh P; Srivastava S; Shivakumar S
    Indian J Dent Res; 2018; 29(3):303-312. PubMed ID: 29900913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted mouth opening.
    Rouleau TS; Manookin KM; Brennan MT
    J Am Dent Assoc; 2012 Jul; 143(7):767-70. PubMed ID: 22751979
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: A randomized controlled trial.
    Piyush P; Mahajan A; Singh K; Ghosh S; Gupta S
    Oral Dis; 2019 Jan; 25(1):73-79. PubMed ID: 30059188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis.
    Mehrotra D; Pradhan R; Gupta S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):e1-10. PubMed ID: 19217007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebamipide to Manage Stomatopyrosis in Oral Submucous Fibrosis.
    Baptist J; Shakya S; Ongole R
    J Contemp Dent Pract; 2016 Dec; 17(12):1009-1012. PubMed ID: 27965488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral lycopene in the management of oral submucous fibrosis.
    Kerr AR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):214-5. PubMed ID: 17234538
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis.
    Cox S; Zoellner H
    J Oral Pathol Med; 2009 Feb; 38(2):220-6. PubMed ID: 18673417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
    Vedeswari CP; Jayachandran S; Ganesan S
    Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aloe vera in the treatment for oral submucous fibrosis - a preliminary study.
    Sudarshan R; Annigeri RG; Sree Vijayabala G
    J Oral Pathol Med; 2012 Nov; 41(10):755-61. PubMed ID: 22650317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional corticosteroids as a treatment for restricted mouth opening in oral submucous fibrosis.
    Tilakaratne WM; Ekanayaka RP; Herath M; Jayasinghe RD; Sitheeque M; Amarasinghe H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):224-31. PubMed ID: 27422421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of clinicofunctional staging of oral submucous fibrosis with qualitative analysis of collagen fibers under polarizing microscopy.
    Ceena DE; Bastian TS; Ashok L; Annigeri RG
    Indian J Dent Res; 2009; 20(3):271-6. PubMed ID: 19884707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline therapy in the management of oral submucous fibrosis.
    Mehrotra R; Singh HP; Gupta SC; Singh M; Jain S
    Asian Pac J Cancer Prev; 2011; 12(4):971-4. PubMed ID: 21790236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
    Auluck A; Rosin MP; Zhang L; Sumanth KN
    J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of efficacy of aloe vera in the treatment of oral submucous fibrosis - a clinical study.
    Anuradha A; Patil B; Asha VR
    J Oral Pathol Med; 2017 Jan; 46(1):50-55. PubMed ID: 27314762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis.
    Bhadage CJ; Umarji HR; Shah K; Välimaa H
    Clin Oral Investig; 2013 Jun; 17(5):1375-82. PubMed ID: 22893038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.